Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$136,485,006
-$20,727,205 QoQ
Shares Held
542,382
-25.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#208
of 4,153 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Life Cycle Investment Partners Ltd holds $545,754,539 across 7 Drug Manufacturers - General names. ABBV ranks #2 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
125,054 | $149,993,531 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
542,382 | $136,485,006 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
521,552 | $65,892,879 | |
| 4 | JNJ |
Johnson & Johnson
|
248,443 | $63,097,068 | |
| 5 | AMGN |
Amgen Inc
|
151,355 | $54,808,672 | |
| 6 | MRK |
Merck & Co., Inc.
|
371,133 | $47,690,590 | |
| 7 | GSK |
GSK plc
|
530,080 | $27,786,793 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,485,006 | 542,382 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $157,212,211 | 722,848 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $109,821,890 | 480,642 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||